Asthma, Asthma Chronic, Breathlessness, COPD, Dyspnea, Shortness of Breath, Wheezing
Conditions
Keywords
Breathlessness, COPD, Asthma, Asthma Chronic, Wheezing, Dyspnea, Shortness of Breath
Brief summary
The Sentinel-001 study aims to identify a combination of biomarkers suitable for triage of breathlessness.
Interventions
Combination of digital and physical tests to objectify measures relevant for breathlessness
Sponsors
Study design
Eligibility
Inclusion criteria
* Aged 18-90 years. * Has experienced episode of breathlessness during the past 12 months triggering interaction with a health care professional. Self-reported breathlessness using any of the following words to describe symptoms will qualify as a presentation of breathlessness regardless of aetiology or severity of symptoms: shortness of breath, tight chest, trouble breathing, breathlessness, dyspnoeic, breathless, asthmatic, suffocating, wheezing, fighting for breath or any equivalent word. Breathlessness does not have to be the primary presenting symptom. * Deemed clinically sufficiently stable to participate according to health care practitioner.
Exclusion criteria
* Inability to understand written local language at a year 5 level. * Not being confident in use of digital technology (smartphone and/or tablet). This will become evident through an inability to use the system. * Inability to enter required study sample data due to diminished consciousness and/or physical or mental capacity regardless of whether this is associated with the breathlessness event. * Received an investigational medical product in the context of a Clinical Trial during the 28 days prior to first probe administration.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Physician assessed severity of breathlessness | 1 day (One-time assessment during a participant reported episode of breathlessness) | Breathlessness requiring admission or supplementary oxygen, breathlessness requiring intervention \< 24 hours, Breathlessness requiring medical intervention within 24 hours without meeting the criteria for severe breathlessness, Breathlessness not requiring any medical intervention within 24 hours other than a dose change in the individuals pre-established pharmacological treatment plan |